Literature DB >> 7921536

Perlecan: a gem of a proteoglycan.

R V Iozzo1.   

Abstract

Perlecan, the main proteoglycan of basement membranes and pericellular spaces, is one of the largest single-chain polypeptides of vertebrate animals. The five modules of perlecan are collated from protein building blocks evolutionarily related to molecules involved in nutrient metabolism, mitogenesis and adhesion. These structural motifs, when translated into multimeric functional units, could be effectively utilized by diverse tissues during development, remodelling or neoplastic growth. The protein is highly conserved across species and the available data indicate that this modular proteoglycan has evolved from ancient ancestors by gene duplication and exon shuffling. The discovery of a related molecule in the nematode C. elegans, and the development of skeletal muscle abnormalities in this animal when the perlecan-like molecule is truncated, opens new avenues of research.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921536     DOI: 10.1016/0945-053x(94)90183-x

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  37 in total

1.  Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.

Authors:  Martina Schneider; Ashraf A Khalil; John Poulton; Casimiro Castillejo-Lopez; Diane Egger-Adam; Andreas Wodarz; Wu-Min Deng; Stefan Baumgartner
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

Review 2.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 4.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

5.  Oxygen-glucose deprivation and interleukin-1α trigger the release of perlecan LG3 by cells of neurovascular unit.

Authors:  Maxim G Saini; Emmanuel Pinteaux; Boyeon Lee; Gregory J Bix
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

Review 6.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 7.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

8.  Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons.

Authors:  Maxim G Saini; Gregory J Bix
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

9.  The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.

Authors:  S Grässel; I R Cohen; A D Murdoch; I Eichstetter; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

10.  Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.

Authors:  Atul Goyal; Chiara Poluzzi; Chris D Willis; James Smythies; Adam Shellard; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.